Evolving Treatment Landscape for Relapsed/Refractory Multiple Myeloma

Ryan Haumschild, PharmD, MS, MBA, leads a discussion surrounding relapsed/refractory multiple myeloma (MM).

Ryan Haumschild, PharmD, MS, MBA, leads a panel surrounding individualized strategies for treating patients with relapse/refractory (RR) MM.

A panel of experts explore burdens facing patients diagnosed with RRMM.

Kathryn Maples, PharmD, BCOP, provides insights regarding unmet needs in treatment for relapsed/refractory multiple myeloma.

A panel of experts navigate the treatment landscape in multiple myeloma.